Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA
Clinical trial NCT06222944 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06222944
- Sponsor
- Peking University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-25
- Primary completion
- 2025-08-25
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.